Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandine Pradier

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|June 4, 2019
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Virology Journal|June 14, 2013
Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasmaAnuj Kumar Tyagi, Amandine Pradier, Odile Baumer, et al.
Frontiers in Immunology|April 12, 2019
Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions <i>in vitro</i>Amandine Pradier, Maria Papaserafeim, Ning Li, et al.
Frontiers in Immunology|January 30, 2023
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantationAmandine Pradier, Samuel Cordey, Marie-Céline Zanella, et al.
Frontiers in Immunology|June 16, 2020
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, et al.
Atherosclerosis|December 2, 2006
Differential functions of tissue factor in the trans-activation of cellular signalling pathwaysCamille Ettelaie, Chao Li, Mary E W Collier, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Open Forum Infectious Diseases|March 4, 2026
Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without LetermovirLéna Royston, Ming Zou, Federico Simonetta, et al.
Open Forum Infectious Diseases|April 28, 2025
Blood Virome After Allogeneic Hematopoietic Stem Cell TransplantationKrisztina Hosszu-Fellous, Samuel Cordey, Stavroula Masouridi-Levrat, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|June 4, 2019
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Virology Journal|June 14, 2013
Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasmaAnuj Kumar Tyagi, Amandine Pradier, Odile Baumer, et al.
Frontiers in Immunology|April 12, 2019
Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions <i>in vitro</i>Amandine Pradier, Maria Papaserafeim, Ning Li, et al.
Frontiers in Immunology|January 30, 2023
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantationAmandine Pradier, Samuel Cordey, Marie-Céline Zanella, et al.
Frontiers in Immunology|June 16, 2020
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, et al.
Atherosclerosis|December 2, 2006
Differential functions of tissue factor in the trans-activation of cellular signalling pathwaysCamille Ettelaie, Chao Li, Mary E W Collier, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Open Forum Infectious Diseases|March 4, 2026
Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without LetermovirLéna Royston, Ming Zou, Federico Simonetta, et al.
Open Forum Infectious Diseases|April 28, 2025
Blood Virome After Allogeneic Hematopoietic Stem Cell TransplantationKrisztina Hosszu-Fellous, Samuel Cordey, Stavroula Masouridi-Levrat, et al.
Pageof 3